Jonathan Philip Siegrist's Insider Trades & SAST Disclosures

Jonathan Philip Siegrist's most recent trade in QuidelOrtho Corporation was a trade of 36,152 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 30, 2026.

Share

Note

This is a custom search result for pattern Jonathan Philip Siegrist.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jan 2026	36,152	36,152	-		-	Restricted Stock Units
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jan 2026	36,150	36,150	-		-	Non-Qualified Stock Options
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	2,448	4,898	-		-	Restricted Stock Units
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	2,448	14,428 (0%)	0%		0	Common Stock
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.41 per share.	29 Jan 2026	1,009	13,419 (0%)	0%	27.4	27,657	Common Stock
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Oct 2025	18,656	37,314	-		-	Restricted Stock Units
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Oct 2025	18,656	18,656 (0%)	0%		0	Common Stock
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.31 per share.	15 Oct 2025	6,676	11,980 (0%)	0%	27.3	182,322	Common Stock
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2025	7,347	7,347	-		-	Non-Qualified Stock Options
QuidelOrtho Corporation	Jonathan Philip Siegrist	EVP of R&D & CTO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2025	7,346	7,346	-		-	Restricted Stock Units

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades